DARE

News Daré Bioscience Posts Narrower Q2 Loss

14d ago

News Dare Bioscience regains Nasdaq compliance with bid price - Investing.com

14d ago

SEC filing DARE Raises $250K via Sale of 50,000 Units, Each Consisting of Series A Preferred Stock and 2 Warrants

14d ago

News Daré Bioscience targets Ovaprene Phase III to reach 2,500 exposure cycles in 2026 as Flora Sync LF5 revenue is expected to begin in June

18d ago

SEC filing DARE Reports $5M Regulation A Offering, 20K Units at $5 Each, 40K Warrants, 4.85M Max Offering Size

42d ago

SEC filing DARE Reclassifies Matz from Class II to III, Reappoints Him, Sets 2026 Election; No Changes to Committee Assignments

45d ago

SEC filing DARE Announces $17.35M Regulation A Offering of 3,470 Units at $5.00 Each Including Series A Preferred Stock and Warrants

49d ago

SEC filing DARE Announces $87.5K Reg A Offering: 17.5K Series A Pref, 35K Warrants at $5/Unit

84d ago

News MiddleGround Capital Completes Add-On for New Eagle Platform with Acquisition of Pi Innovo

119d ago

SEC filing Unregistered Sales of Equity Securities

123d ago

Scanner Unusual volume (z=10.8)

169d ago

Scanner Unusual volume (z=10.8)

170d ago

Scanner Unusual volume (z=10.8)

171d ago